Creative Biolabs-Immuno-oncology

Anti-CD33 (clone DRB2E) SynExpress trc-BF-L/T-E Modified CD8+ T cells (CAT#: ITS-1224-CR1333)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD33 (clone DRB2E). We employs the pCDNA (trc-BFP-LEF/TCF-EcoRI) vector components and the SynExpress system of the Single base pair Knockout/Positive feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CD33
Clone
DRB2E
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
BFP
Promoter
trc
Effector Gene
LEF/TCF
Insertion Sites
EcoRI
Gene Modification
Knockout
Modification Domain
Single base pair
Carrier Type
pCDNA
Transformation Accuracy
0.85
Cell Culture
3D Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.